Medical Devices Market Research Reports

SEARCH REPORTS

Medical Devices Market Research Reports & Consulting

Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also lower medical costs. The growth of the markets for telemedicine and drug eluting stents also demonstrate the growing trend in medicine of using cutting-edge technology to enhance clinical outcomes. MarketsandMarkets tracks vital medical devices markets such as orthopedic devices, cardiovascular devices, surgical devices, therapeutic devices, mobility assist devices, self diagnostic devices, and neurostimulators.

Medical devices refer to a broad range of instruments, machines, implants, apparatuses, software, or other similar items that are specifically designed and manufactured for medical purposes. These devices are used in the prevention, diagnosis, treatment, or management of diseases, injuries, or disabilities in humans.

Medical devices can vary in complexity and function. They can be as simple as tongue depressors, thermometers, or bandages, or as advanced as robotic surgical systems, pacemakers, or imaging machines such as MRI (Magnetic Resonance Imaging) scanners.

The primary objective of medical devices is to improve the quality of patient care by providing accurate and reliable diagnostic information, delivering therapies, or assisting in medical procedures. They are often regulated by governmental bodies, such as the Food and Drug Administration (FDA) in the United States, to ensure their safety, effectiveness, and quality.

Medical devices play a crucial role in modern healthcare and are utilized in various settings, including hospitals, clinics, ambulatory care centers, and home healthcare. They are developed through rigorous research, design, testing, and manufacturing processes to meet specific medical requirements and comply with relevant regulations and standards.

Futuristic scope –

The field of medical devices is constantly evolving, and there are several futuristic trends and advancements that hold great potential for improving healthcare in the coming years. Here are some areas with exciting prospects:

Wearable Medical Devices: Wearable devices, such as smartwatches, fitness trackers, and biosensors, are already gaining popularity. In the future, these devices are expected to become more advanced, capable of monitoring a wide range of health parameters, including blood glucose levels, heart rhythm abnormalities, hydration levels, and more. They can provide real-time data and personalized feedback, enabling individuals to actively manage their health and allowing healthcare providers to deliver more precise care.
Telemedicine and Remote Monitoring: Telemedicine and remote patient monitoring have witnessed significant growth, especially during the COVID-19 pandemic. The integration of medical devices with telemedicine platforms will allow patients to receive remote consultations and continuous monitoring of their health conditions. For instance, wearable devices combined with artificial intelligence (AI) algorithms can detect early signs of health deterioration and alert healthcare professionals, enabling proactive interventions and reducing hospitalizations.
Robotics and Minimally Invasive Surgery: Robotic-assisted surgical systems have already revolutionized certain surgical procedures, offering increased precision and control to surgeons. As technology advances, we can expect more sophisticated robotic systems capable of performing complex surgeries with minimal invasiveness. These advancements may lead to shorter recovery times, reduced complications, and improved patient outcomes.
Implantable Devices and Artificial Organs: Implantable medical devices, such as pacemakers and cochlear implants, have been transforming the lives of individuals with chronic conditions. In the future, we may see the development of more advanced implantable devices, including artificial organs and neural interfaces, that can restore or enhance the functioning of specific body systems. These devices could greatly improve the quality of life for people with disabilities or organ failures.
Nanotechnology and Drug Delivery Systems: Nanotechnology has the potential to revolutionize drug delivery and improve targeted therapies. Nanoscale devices or nanoparticles can be engineered to deliver medications precisely to specific cells or tissues, enhancing their effectiveness while minimizing side effects. Additionally, nanosensors could be used for real-time monitoring of various biomarkers within the body, aiding in early disease detection and personalized treatment approaches.
Artificial Intelligence and Machine Learning: AI and machine learning algorithms have the potential to analyze vast amounts of medical data and assist healthcare professionals in diagnosis, treatment planning, and decision-making. These technologies can help identify patterns, predict outcomes, and provide personalized recommendations based on individual patient data. AI-powered medical devices and diagnostic tools can contribute to more accurate and efficient healthcare delivery.

It's important to note that while these futuristic possibilities hold tremendous promise, their successful implementation will require extensive research, rigorous testing, regulatory approvals, and careful consideration of ethical, privacy, and security aspects.

Merger & Acquisition –

Merger and acquisition (M&A) activities in the medical device industry involve the consolidation, integration, or purchase of medical device companies by other companies. These transactions are typically aimed at achieving strategic objectives, such as expanding product portfolios, entering new markets, gaining competitive advantages, or leveraging synergies.

M&A activities in the medical device sector can take various forms, including:

Horizontal M&A: This involves the merger or acquisition of companies operating in the same or similar areas of the medical device industry. It allows companies to expand their market share, eliminate competition, and achieve economies of scale. For example, a company specializing in orthopedic implants may acquire another orthopedic device manufacturer to broaden its product range and strengthen its market position.
Vertical M&A: Vertical integration occurs when a company acquires or merges with a supplier, distributor, or service provider within the medical device supply chain. This strategy aims to streamline operations, control costs, enhance supply chain efficiency, and improve overall business performance. For instance, a medical device manufacturer may acquire a contract manufacturing organization (CMO) to bring manufacturing capabilities in-house and gain greater control over production processes.
Diversification: Companies may engage in M&A activities to diversify their product offerings or enter new market segments. This strategy allows them to reduce reliance on a single product or market and mitigate risks. For example, a company specializing in cardiovascular devices may acquire a company with expertise in neurovascular devices to diversify its product portfolio and expand into a new therapeutic area.
Technology Acquisition: M&A transactions may occur to acquire innovative technologies or intellectual property rights that complement or enhance existing product lines. This strategy enables companies to stay competitive and drive product innovation. For instance, a company focused on diagnostic imaging may acquire a startup with breakthrough imaging technology to strengthen its product capabilities.
Geographic Expansion: M&A activities can facilitate entry into new geographic markets or enhance the global presence of a company. By acquiring companies with established distribution networks or market access in specific regions, companies can expand their reach and capture new customers. This strategy is particularly relevant for companies seeking international growth opportunities.

M&A transactions in the medical device industry are subject to regulatory scrutiny to ensure compliance with antitrust laws and to assess potential impacts on competition and patient welfare. Companies must also carefully consider factors such as financial valuation, integration challenges, cultural alignment, intellectual property rights, and regulatory compliance during the M&A process.

Overall, M&A activities in the medical device sector are driven by strategic objectives and aim to create synergies, drive growth, and enhance competitiveness in an evolving healthcare landscape.

Key segments in Medical Devices:

The medical device industry encompasses various segments that cater to different healthcare needs and specialties. Here are some key segments within the medical device industry:

Diagnostic Devices: Diagnostic devices are used to detect and diagnose medical conditions. This segment includes devices such as imaging systems (X-ray, MRI, CT scanners), ultrasound machines, blood analyzers, molecular diagnostic instruments, and point-of-care testing devices. These devices provide healthcare professionals with critical information for accurate diagnosis and treatment planning.
Therapeutic Devices: Therapeutic devices are designed to deliver treatments or therapies to patients. This segment includes devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, insulin pumps, infusion pumps, nebulizers, ventilators, and dialysis machines. These devices aid in managing chronic conditions, delivering medications, providing respiratory support, and performing life-sustaining functions.
Surgical Devices: Surgical devices are used during surgical procedures to assist surgeons in performing operations. This segment includes devices such as surgical instruments (forceps, scalpels, retractors), electrosurgical devices, surgical lasers, robotic surgical systems, and surgical staplers. These devices enhance precision, minimize invasiveness, and improve surgical outcomes.
Monitoring Devices: Monitoring devices are used to track and measure physiological parameters of patients. This segment includes devices such as vital signs monitors, electrocardiographs (ECG/EKG), blood pressure monitors, glucose meters, pulse oximeters, sleep apnea monitors, and continuous glucose monitoring systems. These devices provide real-time data on a patient's vital signs, enabling healthcare professionals to monitor their condition and make informed decisions.
Rehabilitation and Assistive Devices: Rehabilitation and assistive devices are designed to aid individuals with disabilities or impairments in their daily activities. This segment includes devices such as prosthetics, orthotics, mobility aids (wheelchairs, walkers), hearing aids, visual aids, and assistive technology for communication and mobility. These devices enhance mobility, sensory functions, and overall quality of life for individuals with disabilities.
Implantable Devices: Implantable devices are surgically placed inside the body to restore or enhance specific bodily functions. This segment includes devices such as cardiac implants (pacemakers, defibrillators), neurostimulators, cochlear implants, artificial joints (hips, knees), and intraocular lenses. Implantable devices aim to improve patient health and function by replacing or augmenting damaged or impaired body parts.
Home Healthcare Devices: Home healthcare devices are designed for use in non-hospital settings, allowing patients to receive care and monitoring in the comfort of their homes. This segment includes devices such as home infusion pumps, home dialysis machines, portable oxygen concentrators, sleep apnea machines, and remote monitoring devices. Home healthcare devices promote patient independence, reduce hospital stays, and enable personalized care.

These segments represent a broad overview of the medical device industry, and there are numerous subcategories and specialized devices within each segment. Advances in technology and innovation continue to drive the development of new and improved medical devices across these segments, aiming to enhance patient care and improve healthcare outcomes.

subsegments in Medical Devices:

The medical device industry consists of numerous subsegments that focus on specific areas of healthcare and address specialized needs. Here are some subsegments within the key segments of medical devices:

Diagnostic Devices:

Imaging Devices: X-ray machines, magnetic resonance imaging (MRI) scanners, computed tomography (CT) scanners, ultrasound systems.
In vitro Diagnostic (IVD) Devices: Blood analyzers, molecular diagnostic instruments, immunoassay systems, point-of-care testing devices.
Diagnostic Imaging Contrast Agents: Contrast media used in imaging procedures to enhance visualization.

Therapeutic Devices:

Cardiac Devices: Implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac monitors, cardiac resynchronization therapy devices.
Diabetes Management Devices: Insulin pumps, continuous glucose monitoring systems, blood glucose meters.
Respiratory Devices: Nebulizers, ventilators, continuous positive airway pressure (CPAP) machines.
Renal Devices: Dialysis machines, hemodialysis catheters, peritoneal dialysis systems.

Surgical Devices:

Minimally Invasive Surgical Devices: Laparoscopic instruments, endoscopes, robotic surgical systems.
Surgical Energy Devices: Electrosurgical devices, laser systems, ultrasonic dissectors.
Surgical Instruments: Forceps, scissors, retractors, scalpels, clamps, suturing devices.
Surgical Navigation Systems: Image-guided surgical systems, computer-assisted surgery devices.

Monitoring Devices:

Vital Signs Monitors: Devices for measuring and monitoring parameters such as heart rate, blood pressure, temperature, and respiratory rate.
Electrocardiographs (ECG/EKG): Devices for recording electrical activity of the heart.
Pulse Oximeters: Devices for measuring oxygen saturation levels in the blood.
Holter Monitors: Portable devices for continuous recording of ECG over a period of time.

Rehabilitation and Assistive Devices:

Prosthetics: Artificial limbs and prosthetic devices.
Orthotics: Devices such as braces, splints, and supports for musculoskeletal conditions.
Mobility Aids: Wheelchairs, walkers, crutches, canes.
Hearing Aids: Devices for individuals with hearing impairments.
Visual Aids: Glasses, contact lenses, magnifiers, visual prostheses.

Implantable Devices:

Cardiac Implants: Implantable pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices.
Neurostimulators: Implantable devices for neuromodulation and electrical stimulation for conditions such as chronic pain, Parkinson's disease.
Artificial Joints: Implantable hip, knee, shoulder, and other joint replacements.
Cochlear Implants: Implantable devices for individuals with severe hearing loss.
Intraocular Lenses: Artificial lenses used in cataract surgery to replace the natural lens.

Home Healthcare Devices:

Home Infusion Pumps: Devices for administering medication or fluids at home.
Home Dialysis Machines: Portable devices for performing dialysis at home.
Portable Oxygen Concentrators: Devices for providing oxygen therapy on the go.
Sleep Apnea Devices: Continuous positive airway pressure (CPAP) machines, oral appliances.
Remote Monitoring Devices: Devices for remote patient monitoring and telehealth services.

These subsegments represent specific areas of focus within each key segment of medical devices, catering to specialized medical needs and conditions. They reflect the diverse range of medical devices available to address various healthcare challenges and improve patient outcomes.

Medical Devices Ecosystem:

Manufacturers: Medical device manufacturers are responsible for designing, developing, and manufacturing medical devices. They conduct research, ensure regulatory compliance, and manage production processes to bring innovative and safe devices to the market.
Regulatory Authorities: Regulatory authorities, such as the FDA in the United States and the European Medicines Agency (EMA) in Europe, play a crucial role in overseeing the safety, efficacy, and quality of medical devices. They establish guidelines, review applications, and issue approvals or clearances to ensure devices meet regulatory standards.
Healthcare Providers: Healthcare providers, including hospitals, clinics, and healthcare professionals, utilize medical devices to diagnose, treat, and monitor patients. They rely on devices for accurate diagnostics, effective therapies, and improved patient care.
Distributors: Distributors act as intermediaries between manufacturers and healthcare providers, facilitating the supply chain and ensuring devices reach end-users. They handle logistics, inventory management, sales, and after-sales support.
Research and Development: Research and development (R&D) institutions, both within companies and academic settings, contribute to the advancement of medical devices. They conduct research, develop prototypes, and explore new technologies to drive innovation and improve medical device functionality.
Testing and Certification Organizations: Testing and certification organizations play a vital role in evaluating the safety, performance, and compliance of medical devices. They conduct testing, inspections, and audits to ensure devices meet quality standards and regulatory requirements.
Healthcare Professionals and Users: Healthcare professionals, including doctors, nurses, and technicians, play a critical role in the proper use and application of medical devices. They receive training, interpret device outputs, and provide care based on device-generated information. Patients and end-users also interact with medical devices for self-monitoring, home healthcare, and managing their health conditions.
Support Services: Support services, such as maintenance and repair providers, calibration laboratories, and technical support teams, assist in device upkeep, troubleshooting, and ensuring devices are functioning optimally.
Data Management and Analytics: With the rise of digital health, data management and analytics have become crucial in the medical devices ecosystem. Software platforms, cloud services, and analytics companies handle data collection, storage, analysis, and integration, enabling insights for personalized care, population health management, and clinical decision support.
Patients and Caregivers: Patients and caregivers are essential stakeholders in the medical devices ecosystem. They rely on devices to monitor health conditions, manage treatments, and enhance quality of life. Their feedback, adherence to device usage, and experience provide valuable insights for device improvement and innovation.

The medical devices ecosystem encompasses a wide range of stakeholders, each playing a distinct role in the development, deployment, and utilization of medical devices to improve healthcare outcomes and patient well-being.

Top players:

The medical device industry is home to several top players that have established themselves as leaders in the global market. Here are some of the prominent companies in the medical device sector:

Medtronic: Medtronic is a multinational medical device company based in Ireland. It offers a wide range of products across various therapeutic areas, including cardiac and vascular, minimally invasive therapies, restorative therapies, and diabetes management. Medtronic is known for its innovative devices such as pacemakers, defibrillators, insulin pumps, and surgical instruments.
Johnson & Johnson: Johnson & Johnson is a diversified healthcare company with a significant presence in the medical device industry. Its subsidiary, Ethicon, is a leader in surgical devices, including sutures, staplers, and energy devices. Johnson & Johnson's medical device portfolio also includes orthopedic implants, cardiovascular devices, diabetes care products, and vision care solutions.
Abbott Laboratories: Abbott is a global healthcare company that develops and manufactures a wide range of medical devices and diagnostics. Its product offerings include cardiovascular devices (e.g., stents, heart valves), diabetes care products (e.g., glucose monitoring systems, insulin pumps), diagnostic instruments, molecular diagnostics, and point-of-care testing devices.
Siemens Healthineers: Siemens Healthineers is a leading medical technology company focused on diagnostic imaging systems, laboratory diagnostics, and advanced healthcare IT solutions. The company's products range from X-ray, CT, and MRI systems to in vitro diagnostics equipment and clinical laboratory analyzers.
GE Healthcare: GE Healthcare, a division of General Electric, provides a comprehensive portfolio of medical devices, including diagnostic imaging systems, ultrasound machines, patient monitoring systems, and life support equipment. The company also offers healthcare IT solutions and services.
Stryker Corporation: Stryker is a global medical technology company specializing in orthopedics, medical and surgical equipment, and neurotechnology and spine products. It offers a wide range of innovative devices for joint replacement, trauma surgery, surgical navigation, and neurovascular interventions.
Becton, Dickinson and Company (BD): BD is a leading global medical technology company that develops and manufactures a diverse range of medical devices and solutions. The company's product offerings include injection and infusion systems, diagnostic systems, surgical instruments, and advanced bioprocessing technologies.
Boston Scientific Corporation: Boston Scientific is a renowned medical device company focused on areas such as cardiovascular interventions, rhythm management, urology and pelvic health, endoscopy, and neuromodulation. It develops and markets devices for procedures like coronary stenting, pacemakers, catheters, and endoscopic tools.
Zimmer Biomet Holdings: Zimmer Biomet is a global leader in musculoskeletal healthcare, specializing in orthopedic implants, surgical instruments, and advanced technologies for joint reconstruction, sports medicine, spine surgery, and dental applications.
Philips Healthcare: Philips Healthcare offers a wide range of medical devices and solutions, including imaging systems (such as CT and MRI), patient monitoring systems, respiratory care devices, and home healthcare solutions. The company focuses on integrating technology and data to improve patient outcomes and healthcare efficiency.

These companies have established strong market positions through their product portfolios, technological innovation, global presence, and commitment to advancing healthcare. However, it's important to note that the medical device industry is highly competitive, and there are several other notable players contributing to the advancement of medical technology.

High grown opportunities:

The medical device industry offers numerous high-growth opportunities driven by various factors such as technological advancements, increasing healthcare needs, and evolving market dynamics. Here are some key areas that present significant growth opportunities in the medical device sector:

Digital Health and Connected Devices: The integration of digital technologies and connectivity in medical devices is transforming healthcare delivery. Opportunities exist in the development of wearable devices, remote patient monitoring systems, mobile health applications, telemedicine platforms, and digital therapeutics. These technologies enhance patient engagement, enable real-time monitoring, and facilitate personalized healthcare delivery.
Minimally Invasive and Robotic-Assisted Surgery: Minimally invasive surgical techniques and robotic-assisted surgery have gained significant popularity due to their potential to reduce invasiveness, shorten recovery times, and improve surgical outcomes. The demand for advanced surgical instruments, robotic systems, and imaging technologies for minimally invasive procedures is expected to grow as more healthcare providers adopt these techniques.
Personalized Medicine and Point-of-Care Diagnostics: Advances in genomics, molecular diagnostics, and personalized medicine have created opportunities for the development of innovative diagnostic devices. Point-of-care testing devices, genetic testing platforms, and companion diagnostics are witnessing growth as they enable targeted treatments, improve disease management, and enhance patient outcomes.
Artificial Intelligence and Machine Learning: Artificial intelligence (AI) and machine learning (ML) technologies have the potential to revolutionize medical devices by improving diagnostic accuracy, predicting patient outcomes, and enabling real-time data analysis. AI-powered imaging systems, predictive analytics tools, and decision support systems are emerging as growth areas within the medical device industry.
Remote Monitoring and Home Healthcare: The shift towards patient-centered care and the aging population have fueled the demand for remote monitoring devices and home healthcare solutions. Remote patient monitoring systems, wearable health trackers, and home-based medical devices are expected to experience significant growth as they enable continuous monitoring, early intervention, and personalized care outside traditional healthcare settings.
Advanced Implantable Devices: The market for implantable medical devices, such as cardiac implants, neurostimulators, and orthopedic implants, continues to grow as the aging population increases and the demand for improved quality of life rises. Advancements in materials, biocompatibility, and design are driving the development of next-generation implantable devices with enhanced functionality and durability.
Emerging Markets: Emerging markets, particularly in Asia, Latin America, and Africa, offer substantial growth opportunities for medical device companies. Rising healthcare expenditures, increasing access to healthcare services, and expanding middle-class populations are driving demand for medical devices in these regions. Companies that can effectively navigate regulatory landscapes, adapt to local needs, and provide affordable solutions have the potential for significant growth in emerging markets.

It's important to note that the medical device industry is subject to regulatory requirements and challenges related to reimbursement, intellectual property, and market competition. Companies that can navigate these complexities while addressing evolving healthcare needs stand to benefit from the high-growth opportunities within the medical device sector.

Challenges in Medical Devices Industry:

The medical device industry faces several challenges that impact its growth, innovation, and market dynamics. Here are some key challenges in the medical device industry:

Regulatory Compliance: Medical devices are subject to strict regulations and standards to ensure safety, efficacy, and quality. Obtaining regulatory approvals, navigating complex compliance requirements, and managing post-market surveillance can be time-consuming and costly for medical device companies.
Reimbursement and Pricing Pressures: Reimbursement policies and pricing pressures pose challenges for medical device manufacturers. Negotiating reimbursement contracts with healthcare payers and demonstrating cost-effectiveness and clinical value are essential to gain market access and sustain profitability.
Technological Advancements and Innovation: The medical device industry is highly competitive, and staying at the forefront of technological advancements is critical. Companies face the challenge of continuously innovating and developing new devices with enhanced features, improved outcomes, and cost-effectiveness.
Intellectual Property Protection: Protecting intellectual property (IP) rights is crucial for medical device companies. The industry is susceptible to patent disputes, infringement issues, and challenges in safeguarding proprietary technologies. Ensuring strong IP protection and defending against potential legal threats are ongoing challenges.
Market Access and Global Expansion: Expanding into new markets, especially international markets, can be challenging due to variations in regulatory requirements, cultural differences, and market dynamics. Establishing distribution networks, complying with local regulations, and understanding market needs are critical for successful market access and expansion.
Cost and Time to Market: Developing and commercializing medical devices involve significant investments in research and development, clinical trials, and manufacturing. Long development timelines, cost overruns, and delays in obtaining regulatory approvals can impact companies' ability to bring products to market in a timely and cost-effective manner.
Healthcare System Adoption: Healthcare systems and providers may be slow to adopt new technologies and devices due to factors such as budget constraints, resistance to change, and concerns about reimbursement. Demonstrating clinical evidence, cost-effectiveness, and addressing barriers to adoption are essential for widespread acceptance and adoption of medical devices.
Data Security and Privacy: With the increasing use of connected devices and digital health technologies, data security and privacy have become critical concerns. Protecting patient data, ensuring cybersecurity measures, and complying with data privacy regulations present ongoing challenges for medical device companies.
Supply Chain Disruptions: Disruptions in the global supply chain, such as raw material shortages, transportation issues, and geopolitical events, can impact the production and availability of medical devices. Ensuring supply chain resilience and mitigating risks are vital to maintain uninterrupted device availability.
Healthcare Cost Containment: Healthcare systems globally are under pressure to contain costs. Medical device companies need to address the cost-effectiveness of their devices, demonstrate economic value, and work collaboratively with healthcare providers to meet cost containment objectives.

Navigating these challenges requires strategic planning, collaboration with stakeholders, investment in research and development, and a deep understanding of market dynamics. Companies that can effectively address these challenges have a better chance of succeeding in the competitive medical device industry.

High CAGR geography:

The Compound Annual Growth Rate (CAGR) of the medical device industry can vary across different geographies due to factors such as population demographics, healthcare infrastructure, regulatory environments, and economic growth. While it is difficult to predict the precise CAGR for specific geographies, there are regions that have shown potential for high growth in the medical device sector. Here are a few geographies that have been identified as having a high CAGR for medical devices:

Asia-Pacific: The Asia-Pacific region has witnessed significant growth in the medical device market. Countries like China, India, and Japan have large populations with increasing healthcare needs. Rising disposable incomes, improving healthcare infrastructure, and government initiatives to enhance healthcare access have contributed to the growth of the medical device sector in this region.
Latin America: Latin America is another geography with a high growth potential for medical devices. Countries such as Brazil, Mexico, and Argentina have expanding middle-class populations and increasing healthcare expenditures. The demand for medical devices in areas such as diagnostic imaging, surgical instruments, and cardiovascular devices is expected to grow in this region.
Middle East and Africa: The Middle East and Africa region is experiencing rapid growth in healthcare infrastructure and spending. Countries like Saudi Arabia, United Arab Emirates, South Africa, and Kenya are investing in modernizing healthcare facilities and expanding access to medical services. This creates opportunities for medical device companies, particularly in areas such as diagnostic imaging, patient monitoring, and surgical equipment.
North America: Despite being a mature market, North America, especially the United States, continues to offer growth opportunities in the medical device sector. Technological advancements, increasing chronic disease prevalence, and a focus on value-based healthcare are driving the demand for innovative medical devices and technologies in this region.
Europe: Europe remains a significant market for medical devices, with countries like Germany, France, and the United Kingdom being major contributors. The region's aging population, favorable reimbursement policies, and a focus on healthcare modernization create opportunities for medical device companies, particularly in areas such as implantable devices, diagnostic imaging, and in vitro diagnostics.

see less

Market Reports

Small Animal Imaging (In-Vivo) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global forecast to 2021

The global small animal imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are propelling the growth of the global small animal imaging market.
- Published: September 2016
- Price: $ 4950
- TOC Available:
Urology Surgical Instruments Market by Product (Endoscopes, Endovision Systems, Peripheral Instruments, Consumables and Accessories), Application (Chronic Kidney Diseases, Benign Prostatic Hyperplasia, Oncology)

The global urology surgical instruments market size is projected to grow at a CAGR of 8.2%. The growth of this market can be contributed to rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population.
- Published: September 2016
- Price: $ 4950
- TOC Available:
North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) - Global Forecast to 2021

The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is primarily driven by the rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements. However, risk of needlestick injuries and side effects related to drugs are expected to restrain the growth of this market in the coming years.
- Published: August 2016
- Price: $ 4950
- TOC Available:
Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market by Product/Brand (GEM 4000, GEM 3000, i-STAT, ABL900, ABL90, cobas b 221, RAPIDLab), Player/Company (Radiometer, Instrumentation Laboratory, Siemens, Abbott, Alere) - Global Forecasts to 2021

The global market for blood gas analyzers was estimated to be USD 506.9 Million in 2016, which would reach USD 636 Million by 2021, growing at a CAGR of 4.6% during 2016 to 2021. Owing to the increasing demand for point of care and automated blood gas analyzers, this market is expected to witness decent growth in the coming years. An increase in number of patients being treated in ICUs, NICUs and emergency departments would further accelerate the pace of growth of blood gas analyzers market.
- Published: July 2016
- Price: $ 4950
- TOC Available:
Medical Animation Market by Type (3D, 2D, 4D), Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), Application (Drug MoA, Patient Education), End User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021

This report studies the global medical animation market for the forecast period of 2016 to 2021. This market is expected to reach USD 301.3 Million by 2021 from USD 117.3 Million in 2016, at a CAGR of 20.8%. Major players in the medical animation market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.).
- Published: May 2016
- Price: $ 4950
- TOC Available:
Medical Suction Devices Market by Type (AC-Powered, Battery-Powered, Dual, Manually Operated), Application (Surgical, Airway, R&D), Portability (Handheld, Wall-Mounted), End User (Homecare, Hospitals and Clinics, Prehospitals)

The global medical suction devices market size is projected to grow at CAGR of 3.9%. Major factors driving the growth of this market is, the paradigm shift from traditional healthcare settings to home healthcare and the increasing need for compact and portable devices. Moreover, the rising adoption of home care has led to the increased demand of portable suction devices, as they are reliable & easy to use and have high durability & robustness. This helps healthcare providers and patients to use suction devices without any assistance.
- Published: May 2016
- Price: $ 4950
- TOC Available:
Craniomaxillofacial Implants Market by Type (Mid Face, Plates, Screws, Mandibular Orthognathic Implants, Neuro, Mesh, Bone Graft, Dural Repair), by Material of Construction (Titanium, Polymer), by Application Site & Property

The global Craniomaxillofacial implants market size is projected to grow at a CAGR of 6.9%. The market is broadly classified into type, application site, material of construction, property and regions.
- Published: May 2016
- Price: $ 4950
- TOC Available:
Varicose Vein Treatment Market by Products (Laser & RF Ablation, Venous Closure, Surgical), Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Region (North America, Europe)

The varicose vein treatment market size is projected to grow at a CAGR of 6.9%. The swollen, twisted veins that are visible under the skin are termed as varicose veins.
- Published: May 2016
- Price: $ 4950
- TOC Available:
Asia and North Africa Critical Care Equipment Market by Product (Infusion Pumps, Ventilators, & Patient Monitors) - Competitive Analysis & Forecasts to 2021

The critical care equipment market for asia and north Africa is expected to reach $2.61 billion by 2021 from $1.78 billion in 2016, at a CAGR of 8.0% during the forecast period. Continuous technological advancements in critical care devices, increasing government support, growing private sector investments in the healthcare industry, and increasing patient population base are key factors fuelling the growth of the global market of critical care equipment in the emerging nations.
- Published: May 2016
- Price: $ 4950
- TOC Available:
Asia and North Africa Hemodialysis & Peritoneal Dialysis Market by Products (Machine, Dialyzer, Bloodlines, Concentrates, Catheters, & Transfer Sets) and Services (In-Center and Home) - Forecast to 2020

The dialysis market in emerging nations is projected to grow at a CAGR of 9.2% during the forecast period, and is expected to reach a value of USD 35.9 Billion by 2020. The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations. Furthermore, low preference of patients for kidney transplantation, technological advancements, and substantial government healthcare expenditure on the treatment of ESRD are adding to the growth prospects of dialysis products and services market in the emerging nations.
- Published: May 2016
- Price: $ 4950
- TOC Available:
Biochips Market Size & Share by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), Fabrication Technology (Microarrays, Microfluidics), End user (Academics Institutes, Diagnostics Centers) - Global Forecast to 2020

is 2015 and the forecast for the market size is provided for the period between 2015 and 2020. In the current market scenario, biochips are increasingly adopted in various applications in the field of genomics, drug discovery, and proteomics. In addition, the development of targeted and personalized medicines for the treatment of cancer and technological advancements in biochips are also supporting the growth of biochip products.
- Published: May 2016
- Price: $ 4950
- TOC Available:
Medical Robots Transforming Healthcare – Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle

Medical robots are devices that are used to improve the quality of care for patients. The major types of medical robots are surgical robots, hospital and pharmacy robots, rehabilitation robots, and non-invasive radiosurgery robots. Each type of robots vary widely in prices, offer varied benefits & cost-saving advantages, and are subject to different reimbursement structures, buying cycle, price wars, and other factors.
- Published: April 2016
- Price: $ 4950
- TOC Available:
Bathroom and Toilet Assist Devices Market by Product Type (Chairs & Stools, Bath Lifts, Toilet Seat Raisers, Toilet Aids, Commodes, Handgrips & Grab Bars, Bath Aids), Region (North America, Asia-Pacific, Europe, Row)

The global bathroom and toilet assist devices market size is projected to grow at a CAGR of 5.7%. Factors, such as rise in the aging population, growing rate of awareness about assistive devices, and technological advancement are driving the growth of this market.
- Published: April 2016
- Price: $ 4950
- TOC Available:
Polymerase Chain Reaction Market – Usage Pattern and Replacement Trends, End User Analysis, Pricing Analysis, Comparative Analysis, Competitive Landscape Comparative Analysis and End User Preference Study

Polymerase chain reaction (PCR) is one of the revolutionary life science technologies that has not only made tremendous impact on the scientific community, but also affected many aspects of diseases diagnosis and treatment. The overall market for Polymerase chain reaction (PCR) technology has observed steady growth due to the expansion in its application areas and increased accuracy and precision. Specific technology segments of the PCR market, such as dPCR (digital PCR) and qPCR (real-time PCR), are witnessing higher market growth owing to their benefits such as real-time process monitoring, low reagent consumption, automation of workflow, and greater reproducibility and precision.
- Published: March 2016
- Price: $ 4950
- TOC Available:
US In Vitro Diagnostics Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & Region

The US In vitro diagnostics market size is projected to grow 4.7%. Some of the key factors driving the growth of this market are the rising incidence of chronic and infectious diseases in the U.S., rapidly aging population, growing preference for point-of-care testing and personalized medicine, implementation of the Affordable Care Act (ACA), increasing adoption of automated instruments, and automation in laboratories.
- Published: March 2016
- Price: $ 12000
- TOC Available:
Asian Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation KIT, HIV Test, ECG, EKG, EEG, Hearing Aids, Ventilator, Cane, Walker, Wheelchairs), Services (Rehabilitation, Skilled, Hospice, Palliative Care), & Telehealth

The Asian home healthcare market size is projected to grow at a CAGR of 9.8%. The major factors driving the growth of this market include the rapidly increasing aging population, increasing incidences of chronic diseases, growing demand for affordable healthcare delivery systems due to increasing healthcare costs, technological advancements, and government initiatives to promote home healthcare. On the other hand, limited insurance coverage, lack of awareness about home healthcare, and patient safety concerns are major factors restricting the growth of this market.
- Published: March 2016
- Price: $ 4950
- TOC Available:
Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW)

The global walking assist devices market size is projected to grow at a CAGR of 3.9%. The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, new product launch, M&A, and product approvals of the major companies would be detailed. Honda Motor Co., Ltd., Permobil Inc., GF Health Products, Inc., Invacare Corporation, Besco Medical Co., LTD., Betterlifehealthcare Ltd., C.T.M. Homecare Product, Inc., Ottobock, Ossenberg GmbH, Pride Mobility Products Corp., Aetna Inc., Sunrise Medical (US) LLC, and Karma Healthcare Ltd., are some of the key players operating in this market
- Published: February 2016
- Price: $ 4950
- TOC Available:
Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast to 2020

The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020. Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the medical automation market. However, high cost of automation is one of the key restraints for this market.
- Published: February 2016
- Price: $ 4950
- TOC Available:
Pressure Monitoring Market Size & Share by Product (Device (Blood Pressure, Intracranial Pressure, Intraocular Pressure), Accessory), Application (Respiratory, Glaucoma, Dialysis), Procedure (Invasive), End User (Hospital, ASC, Diagnostic)

The global pressure monitoring market size is projected to grow at a CAGR of 5.0%. Factors such as rising prevalence of chronic and acute diseases increase in the aging population, new product launches, and technological advancements are driving the growth of global market for pressure monitoring. On the other hand, high cost of technological advancements, lack of trained professionals, accuracy of the devices and short shelf life is hindering the growth of market for pressure monitoring.
- Published: January 2016
- Price: $ 4950
- TOC Available:
Operating Room Equipment Market by Equipment (Anesthesia Machines, Operating Tables), by Supplies (Surgical Instruments, Disposable Materials), & by End-User (Hospitals, Outpatient Facilities)

The global operating room equipment market size is projected to grow at a CAGR of 3.7%. The growth of this market can be attributed to the growing investments, funds, and grants by government bodies worldwide, rising number of hospitals, increasing patient preference for minimally invasive surgeries, growing number of regulatory approvals for operating room equipment, and growing number of geriatric population coupled with the increasing number of surgeries globally.
- Published: January 2016
- Price: $ 4950
- TOC Available:
HIP Replacement Devices Market by Product (Primary HIP Replacement (Cemented, Cementless), Partial HIP Replacement, Revision HIP Replacement, HIP Resurfacing), Geography (Americas, EU-5, Japan, BRIC, South-East Asia, MEA) - Forecast to 2020

The total hip replacement is also referred to as total hip arthroplasty/hip resurfacing. It is a very common surgery that helps to minimize pain and rigidity in the hip joint. The total hip replacement is categorized into four segments, namely, primary hip reconstruction, partial hip reconstruction, hip resurfacing, and revision hip implants. The global hip reconstruction market was valued at USD 4.8 Billion in 2014 and is expected to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015-2020.
- Published: January 2016
- Price: $ 4950
- TOC Available:
Knee Reconstruction Devices Market by Product Type (Primary (Cemented & Cementless), Partial, and Revision Implants), and Geography (U.S., Canada, Eu-5, Japan, Bric, Turkey, Indonesia - Global Analysis and Forecast to 2020

The global knee reconstruction devices market size is projected to grow at a CAGR of 4.3%. The growth rate of knee reconstruction surgeries is influenced by various factors, such as rise in the aging population and prevalence of arthritis, technological advancements, and well-structured healthcare policies in most of the countries.
- Published: January 2016
- Price: $ 4950
- TOC Available:
Powered Surgical Instruments Market by Power Source (Electric, Battery, Pneumatic), Product (Drill, Saw, Stapler, Reamer, Battery, Console, Cables, Blade, Burr, Cart) & by Application (Orthopedic, ENT, Oral, Thoracic, Neurology) - Global Forecast to 2020

The global powered surgical instruments market is estimated to be worth around USD 1.7 Billion in 2014 and is expected to reach around USD 2.2 Billion to grow at a CAGR of 4.1% during the forecast period of 2015 to 2020. This market is mainly driven by increasing aging population, high prevalence of chronic disorders requiring surgical interventions, and high disposable income among consumers.
- Published: December 2015
- Price: $ 4950
- TOC Available:
Latin America Orthodontic Supplies Market by Removable & Fixed Braces (Brackets (Self Ligating, Lingual), Archwire (Nickel Titanium, Stainless Steel), Anchorage Appliances (Buccal Tube, Band), Ligature (Elastomeric, Wire)) & Adhesives - Forecast to 2020

The Latin American orthodontic supplies market is valued at USD 110.0 million in 2015 and expected to reach USD 133.6 million by 2020, at a CAGR of 4.0% from 2015 to 2020. A number of factors such as the growing number of patients with malocclusions, lower cost of orthodontic treatment in Latin American countries as compared to other developed nations, higher concentration of orthodontics associations, decreasing trade barriers for medical devices in some Latin American countries, and rising disposable incomes in countries such as Brazil, Mexico, and Chile are propelling the growth of the Latin American orthodontic supplies market. The major players in the Latin American orthodontic supplies market include Dental Morelli (Brazil), 3M Unitek Corporation (US), American Orthodontics (US), DENTSPLY International (US), Ormco Corporation (US), Orthometric (Brazil), and FORESTADENT (Germany).
- Published: December 2015
- Price: $ 4950
- TOC Available:
Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020

The global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation holds a larger market share and is poised to grow at a CAGR of 14.5% during the forecast period.
- Published: December 2015
- Price: $ 4950
- TOC Available:
Dental Lasers Market by Product (Soft Tissue, All Tissue, Dental Welding Lasers), Application (Conservative Dentistry, Endodontic Treatment, Periodontitis), End User (Hospitals, Clinics), and Geography - Global Forecast to 2020

The global dental laser market is expected to reach USD 224.7 Million by 2020, at a CAGR of 5.2% during the forecast period from 2015 to 2020. The rising middle class and aging population; increasing awareness for oral hygiene, reduced treatment time, and operating cost; and rising demand for cosmetic dentistry have influenced the growth of the dental lasers market. The increasing technological advancements are further expected to drive the growth of the market.
- Published: November 2015
- Price: $ 4950
- TOC Available:
Spine Biologics Market by Product Type (Bone Graft, Bone Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020

Spinal biologics encompass materials that can be utilized in case of bone fusion surgery, spinal cord injury, and degenerative disk disease. Ten years ago, the spine treatment market constituted 75% traditional rods and plates made of metals and 25% biologics. However, since metals are inert materials, they did not stimulate the bone regeneration process. On the other hand, biological materials are proteins that can attract and stimulate cells, promote fusion, and help in the bone healing process. . The global spine biologics market is expected to reach $2.4 Billion by 2020, at a CAGR of 4.4% during the forecast period from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
Latin America Medical Gases & Equipment Market by Product (Oxygen, Medical Air, Nitrogen, Carbon Dioxide, Nitrous Oxide, Helium, Ethylene Oxide, Blood-gas Mixture, Cylinder, Hoses, Manifold, Regulator) End User (Hospital, Home Care) - Forecast to 2020

The Latin America medical gases & equipment market is estimated to reach around USD 1.8 Billion by 2020 at a CAGR of 10.2% during the forecast period of 2015 to 2020. The Latin America medical gases & equipment market is witnessing considerable growth owing to the high prevalence of respiratory diseases, rising geriatric population, high prevalence of tobacco smoking, urbanization, growing levels of pollution, and changing lifestyles.
- Published: November 2015
- Price: $ 4950
- TOC Available:
Anesthesia Monitoring Devices Market by Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstations), End User (Hospital, Ambulatory Surgery Centers), and Geography - Global Forecast to 2020

The requirement of anesthesia monitoring devices basically depends on the types of cases performed in the operating room. The parameters to be considered for anesthesia monitoring devices include continuous assessment by measurement of patient’s oxygenation, ventilation, circulation, and temperature. The global anesthesia monitoring devices market was valued at USD 820.9 Million in 2014 and is expected to reach USD 1,616.0 Million by 2020, at a CAGR of 12.0% from 2015 to 2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020

Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
Anti-snoring Devices and Snoring Surgery Market by Device Type (MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, EPAP), Surgical Procedure (UP3, LAUP, RFA, Sclerotherapy, Pillar, Others (Septoplasty, ESS)) - Global Trends & Forecast to 2020

The anti-snoring treatment market is poised to reach USD 1,232.6 Million by 2020 from USD 744.7 Million in 2015, growing at a CAGR of 10.6% from 2015 to 2020. Major factors driving the growth of this market include the growing awareness regarding the ill effects of snoring, availability and benefits of anti-snoring treatments, growing geriatric and obese population, presence of a large number of cigarette smokers and alcoholics, and a large pool of untapped snoring population. However, poor efficacy of current anti-snoring treatments available in the market, high cost of some of the anti-snoring treatments, and lack of reimbursement are major factors restraining the growth of this market.
- Published: September 2015
- Price: $ 4950
- TOC Available:
Nuclear Medicine Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), hybrid PET, & Planar Scintigraphy), Application (Cardiology, Oncology & Neurology) & by End user (Hospitals, Imaging Centers) - Global Forecasts to 2020

Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. The nuclear medicine equipment market is expected to grow at a single-digit CAGR in the next five years. This market is poised to reach USD 2.13 Billion by 2020 from USD 1.78 Billion in 2015, at a CAGR of 3.6% during the forecast period.
- Published: September 2015
- Price: $ 4950
- TOC Available:
Antimicrobial Coatings for Medical Devices Market by Type of Material (Metallic Coatings (Silver Coatings), Non-metallic Coatings (Polymeric Coatings) & Device Type (Catheters, Implantable Devices, Surgical Instruments) - Global Forecast to 2020

The antimicrobial coatings for medical devices market is segmented on the basis of type of material, device types, and regions. The global antimicrobial coatings for medical devices market is expected to grow at a CAGR of 14.2% from 2015 to 2020 to reach USD 1.17 Billion by 2020 from USD 0.61 Billion in 2015. Factors such as rising awareness about hospital-acquired infections, favorable research and funding environment, technological advancements in antimicrobial coatings, growing implantable devices market, increasing research and development activities for antimicrobial coated cardiovascular devices, high growth in geriatric population, and increasing burden of cardiovascular diseases across the globe are driving the growth of this market.
- Published: September 2015
- Price: $ 4950
- TOC Available:
Medical Lifting Sling Market by Product (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric), by Material (Nylon, Padded, Canvas), by Usage Type (Disposable, Reusable), End User (Home, Hospital, Elderly) -Forecast to 2020

In this report, the medical lifting sling market is broadly segmented on the basis of product, usage type, material, end user and region. On the basis of products, the medical lifting sling market is broadly segmented into standing slings, seating slings, universal slings, hammock slings, transfer slings, toilet slings, bariatric slings, and others (such as positioning and pivot slings). The transfer sling segment is expected to be the largest segment and will also be the fastest growing segment in the forecast period. This growth can be attributed to the multi-purpose application of the sling. The medical lifting sling market is estimated to grow at a CAGR of 11.4% to reach USD 706.0 Million by 2020.
- Published: August 2015
- Price: $ 4950
- TOC Available:
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020

The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
Medical Videoscope Market by Scope [Rigid (Laparoscope, Ureteroscope), Flexible (Colonoscope, Gastroscope)], Visualization Systems (Monitors, HD Camera, 3D Camera, Light Source), by Application (Colonoscopy, Laparoscopy, Arthroscopy) - Global Forecasts to 2019

Medical videoscope have huge demand across the globe owing to their wide application areas as well as their flexibility in terms of specification of instruments, which fits in with the various requirements of different procedures. The market has seen an extraordinary amount of technological advancements and breakthroughs in the last few years, as companies have focused on developing products capable of reducing pain, curtailing the number of sick days, and reducing the overall cost of treatment. The global medical videoscopes market was valued at $13.6 Billion in 2014 and is expected to reach $19.0 Billion by 2019, growing at a CAGR of 7.0% from 2014 to 2019.
- Published: April 2015
- Price: $ 4950
- TOC Available:
Cannula Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, Cardioplegia, Suction, Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2020

The cannula market is estimated to grow at a CAGR of 5.6% from 2015 to 2020 to reach $135.5 million by 2020.The report segments the global cannula market by product, by material, by application, by end-users and region. On the basis of material, the market is divided into plastic, metal and silicone. The silicone material is estimated to be the fastest growing segment during the forecast period. On the basis of end users, the cannulas market is divided into hospitals, ambulatory surgical centers, and others (blood banks and home healthcare facilities).
- Published: April 2015
- Price: $ 4950
- TOC Available:
Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast to 2019

The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, growing at a CAGR of 7.41% between 2014 and 2019. Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014–2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, high cost of equipment and software and reimbursement issues may hinder the growth of this market.
- Published: March 2015
- Price: $ 4950
- TOC Available:
Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019

The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014–2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent. The global nanotechnology-based medical devices market was valued at around $5 billion in 2014 and is poised to grow at a CAGR of around 11-12% during the forecast period (2014 to 2019).
- Published: March 2015
- Price: $ 4950
- TOC Available:
Lab Accessories Market by Type (Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology & Pharmaceutical Companies/Hospital/Private Labs/Research Institute) - Global Forecast to 2020

The laboratory accessories market is valued at $327.0 million in 2014. It is expected to reach $504.7 million by 2020, growing at a CAGR of 7.5% from 2014 to 2020. The laboratory accessories market is dominated by North America, it is followed by Europe, Asia and Rest of the world. The Asian market is the fastest growing in the forecast period (2014-2020). Reagent reservoirs is the fastest-growing segment of this market.
- Published: March 2015
- Price: $ 4950
- TOC Available:
European Patient Handling Equipment Market by Product (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory), by Type of Care (Bariatric, Critical, Wound, Fall), by Accessories (Lifting, Transfer), by End User (Hospital, Elderly) - Forecast to 2019

The European patient handling equipment market is estimated to grow at a CAGR of 11.4% to reach $5,150.2 million by 2019. The nonmechanical equipment product segment is expected to witness the fastest growth during the forecast period. The European patient handling equipment market by region is segmented into Germany, the U.K., France, Sweden, Denmark, Spain, the Netherlands, Italy, and Rest of Europe (RoE).
- Published: January 2015
- Price: $ 4950
- TOC Available:
Single Tooth Implants and Dental Bridges Market by Product (Single Tooth Implants, Dental Bridges), by Type (3-unit, 4-unit, Maryland, Cantilever, Partial), by Material (PFM, All Ceramics and Metal Alloys) - Global Forecasts to 2019

The global single-tooth implants and dental bridges market is valued at $3,297.6 million in 2014 and is poised to grow at a CAGR of 7.3% during the forecast period of 2014 to 2019. Rising incidences of dental caries and other periodontal diseases among the aging baby-booming populationand growing aging population who are more prone to tooth loss are the major factors driving the growth of this market. In addition, better hygiene and aesthetics associated with the usage of single-tooth implants is expected to drive the growth of the single-tooth implants, as opposed to dental bridges.
- Published: October 2014
- Price: $ 4950
- TOC Available:
North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018

The North American interventional cardiology and peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S.
- Published: June 2014
- Price: $ 4950
- TOC Available:
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018

The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions.
- Published: March 2014
- Price: $ 4950
- TOC Available:
Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018

The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.
- Published: August 2013
- Price: $ 4950
- TOC Available:
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017

The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
- Published: July 2013
- Price: $ 4950
- TOC Available:
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017

The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
- Published: June 2013
- Price: $ 4950
- TOC Available:
North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017

The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
- Published: May 2013
- Price: $ 4950
- TOC Available:
Additive Manufacturing Market , By Application (Medical Devices, Automotives, & Aerospace) and Technology (3D Printing, Laser Sintering, Stereolithography, Fused Deposition Modeling, Electron Beam Melting, & Tissue Engineering) - Forecast (2012 - 2017)

According to the American Society for Testing and Materials (ASTM), ’additive manufacturing’ is the “process of joining materials to make objects from 3D model data, usually layer upon layer”. Various synonyms generally used for AM are additive fabrication, additive processes, additive techniques, additive layer manufacturing, layer manufacturing, and freeform fabrication. The AM market can be applied in various industries such as motor vehicles, consumer products, business machines, medical, academic, aerospace, government/military, and others (architecture, paleontology, and forensic pathology). In this report, we are mainly focusing on the medical applications of AM.
- Published: April 2013
- Price: $ 4950
- TOC Available:
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017

The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available: